氰基丙烯酸酯非肿胀麻醉消融与大隐静脉激光消融的对比
该回顾性研究比较了n-丁基氰基丙烯酸酯(NBCA)非肿胀麻醉消融(VariClose Vein Sealing System,VVSS)与腔内激光消融(EVLA)治疗大隐静脉功能不全的疗效。
要点
- VVSS平均手术时间7分钟,短于EVLA的18分钟(P<.01)。
- VVSS无需肿胀麻醉,色素沉着和静脉炎发生率低于EVLA。
核心结论
- NBCA静脉封堵系统是治疗大隐静脉功能不全快速有效的方法,无需肿胀麻醉、弹力袜,且不引起感觉异常、灼伤痕迹或色素沉着。
- 仍需更大规模、长期随访研究以确定大隐静脉功能不全的最佳治疗方式。
研究设计与样本
- 回顾性比较研究,2013年5月至2014年8月共纳入339例大隐静脉功能不全的静脉曲张患者,分别接受VVSS或EVLA治疗。
- 收集并回顾性比较患者术前、术中、术后及随访数据。
主要发现
- VVSS组平均年龄45.09±12岁,EVLA组47.08±11岁(P=.113);平均消融静脉长度分别为31.97±6.83 cm和31.65±6.25 cm(P=.97)。
- EVLA组平均使用肿胀麻醉300 mL(范围60-600 mL);VVSS组平均手术时间7分钟(范围4-11分钟),EVLA组18分钟(范围14-25分钟)(P<.01)。
- 术后即刻超声显示两组所有手术均成功,靶静脉段完全闭塞;12个月总闭塞率VVSS组98.6%、EVLA组97.3%(P=.65)。
- 两组静脉临床严重程度评分均显著下降,组间无差异;VVSS组不良事件少于EVLA组(色素沉着P≤.002;静脉炎P≤.015)。
关键数值与推荐
- 12个月总闭塞率:VVSS组98.6%,EVLA组97.3%(P=.65)。
- 平均手术时间:VVSS组7分钟(范围4-11分钟),EVLA组18分钟(范围14-25分钟)(P<.01)。
- 平均消融静脉长度:VVSS组31.97±6.83 cm,EVLA组31.65±6.25 cm(P=.97)。
- 不良事件:色素沉着P≤.002,静脉炎P≤.015,VVSS组少于EVLA组。
临床怎么用
- 对 incompetent 大隐静脉可选择NBCA非肿胀麻醉消融,手术时间短且无需肿胀麻醉,短期闭塞率与EVLA相当。
- VVSS术后色素沉着和静脉炎更少,可作为关注微创与美观患者的可选方案。
局限性
- 为回顾性研究,随访时间截至12个月,作者指出仍需大规模长期随访研究确认最佳治疗方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The endovenous application of n-butyl cyanoacrylate (NBCA) is a new nontumescent ablation technique for the treatment of venous insufficiency. The aim of this study was to retrospectively compare an NBCA-based ablation method with endovenous laser ablation (EVLA) for the management of incompetent great saphenous veins. METHODS: Between May 2013 and August 2014, there were 339 patients with incompetent varicose veins who were treated with either the endovenous application of NBCA (VariClose Vein Sealing System [VVSS]; Biolas, Ankara, Turkey) or EVLA. The preprocedural, intraprocedural, postprocedural, and follow-up data of the patients were collected and retrospectively compared. RESULTS: The mean age was 45.09 ± 12 years in the VVSS group and 47.08 ± 11 years in the EVLA group (P = .113). The average ablated vein length was 31.97 ± 6.83 cm in the VVSS group and 31.65 ± 6.25 cm in the EVLA group (P = .97). The average tumescent anesthesia use was 300 mL (range, 60-600 mL) in the EVLA group. The average procedure time was 7 minutes (range, 4-11 minutes) in the VVSS group and 18 minutes (range, 14-25 minutes) in the EVLA group (P < .01). On the basis of ultrasound examinations performed at the end of the procedure, all procedures in both groups were successful, and the target vein segments were fully occluded. The 12-month total occlusion rates in the VVSS and EVLA groups were 98.6% and 97.3%, respectively (P = .65). In both the VVSS and EVLA groups, the Venous Clinical Severity Score declined significantly with no difference between groups. There were fewer adverse events after VVSS treatment compared with EVLA treatment (pigmentation, P ≤ .002; phlebitis, P ≤ .015). There was no need for tumescent anesthesia in the VVSS group. CONCLUSIONS: The NBCA-based vein sealing system is a fast and effective treatment option for the management of incompetent saphenous veins that does not involve tumescent anesthesia, compression stockings, paresthesia, burn marks, or pigmentation. Further large-scale studies with long-term outcomes are required to identify the optimal treatment modalities for patients with saphenous vein insufficiency.
引用
- Koramaz İ, El Kılıç H, Gökalp F, et al. Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28214489. doi:10.1016/j.jvsv.2016.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。